Search results
This page contains resources that may be of help in your daily practice, like the proposed universal NOAC patient card, links to the AF guideline text and the practical guide itself, as well as links to a slide set and a key-messages booklet of the practical guide.
25 kwi 2021 · NOACs have an improved efficacy/safety ratio and a predictable anticoagulant effect without the need for routine coagulation monitoring. 6,7 However, the proper use of NOACs requires a carefully considered approach to many practical aspects.
4 wrz 2021 · In the 2021 EHRA Practical Guide on the use of NOACs, we suggest to consider NOAC plamsa level assessment in two different types of scenarios: emergency situations (e.g. acute ischaemic stroke, necessity for urgent surgery) on the one hand, and uncertainty about steady state NOAC plasma levels (e.g. multiple drug–drug interactions, chronic kidne...
25 kwi 2021 · In this review article, we discuss the evidence available to guide DOAC selection and dosing in AF patients with different stages of renal insufficiency and clearance capacities (Table 1). ... ...
19 paź 2021 · Atrial fibrillation (AF) is the most common cardiac arrhythmia associated with an increased risk of stroke and thromboembolism, which can be prevented with the use of anticoagulants 1 such as Vitamin K antagonists (VKAs) or non-vitamin K antagonist oral anticoagulation (NOAC) agents.
2021 European Heart Rhythm Association Practical Guide on the useofnon-vitamin Kantagonist oral anticoagulants inpatients with atrialfibrillation Tableofcontents. 2 1.NOAC eligibilityanddosing Selectedindicationsandcontra-indications Hatched–Limiteddata Condition Eligibility for NOAC therapy Comment
NOAC eligibility and dosing NOAC eligibility NOACs are approved for stroke prevention in ‘non-valvular’ AF. Most SmPCs base eligibility on the CHADS 2 score as it was com-monly used in the phase III randomized clinical trials (RCTs). Given the consistent efficacy and safety, the indication for NOAC therapy
